TP53 and neoplasm: The exacerbation of the chronic inflammation mediated by p53 inactivation promotes the activation of myeloid-derived suppressor cells (e.g. precursors of dendritic cells, macrophages and granulocytes that inhibit T cell response), shifting the nature of the tumor microenvironment further towards a pro-tumorigenic phenotype (10).